SillaJen is a South Korea-based biotechnology company that develops and commercializes oncolytic virus immunotherapeutics for the treatment of cancer.
Business Model:
Revenue: $2M
Employees: 11-50
Address: 109, Sogong-ro
City: Jung-gu
State: seoul teugbyeolsi
Zip: 04525
Country: KR
SillaJen is a South Korea-based biotechnology company that develops and commercializes oncolytic virus immunotherapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2016 | Equity | 1 | $12M |
Medivate Partners Medivate Partners Medivate Partners Medivate Partners |
---|
Announced Date | Name | Price |
---|---|---|
11/2013 | Jennerex Biotherapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|